Literature DB >> 4005112

Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.

J Godbillon, D Evard, N Vidon, M Duval, J P Schoeller, J J Bernier, J Hirtz.   

Abstract

The colonic absorption of metoprolol was indirectly evaluated by measuring drug appearance in plasma following intravenous, jejunal or colonic infusion in six healthy volunteers. Plasma concentrations of alpha-hydroxymetoprolol and urinary excretion of the main metabolites were also measured. Plasma profiles of metoprolol after colonic and jejunal perfusion were similar, and the relative bioavailabilities of the drug from these two regions of the gut were not significantly different. The concentrations of alpha-hydroxymetoprolol, the major metabolite in plasma, were similar after jejunal and colonic perfusion, but higher than those observed after intravenous administration. The percentage of the dose recovered in urine over 24 h as two metabolites was not significantly influenced by the route of administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005112      PMCID: PMC1463759          DOI: 10.1111/j.1365-2125.1985.tb02751.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Metabolism of metoprolol-(3-h) in man, the dog and the rat.

Authors:  K O Borg; E Carlsson; K J Hoffmann; T E Jönsson; H Thorin; B Wallin
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.

Authors:  J B Lecaillon; P Massias; J P Schoeller; F Abadie
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  Determination of two metoprolol metabolites in human urine by high-performance liquid chromatography.

Authors:  J Godbillon; M Duval
Journal:  J Chromatogr       Date:  1984-07-13

4.  Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

Authors:  C G Regårdh; K O Borg; R Johansson; G Johnsson; L Palmer
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

5.  Oxidation phenotype--a major determinant of metoprolol metabolism and response.

Authors:  M S Lennard; J H Silas; S Freestone; L E Ramsay; G T Tucker; H F Woods
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

6.  Determination of metoprolol and its alpha-hydroxylated metabolite in human plasma by high-performance liquid chromatography.

Authors:  J B Lecaillon; J Godbillon; F Abadie; G Gosset
Journal:  J Chromatogr       Date:  1984-02-10

7.  Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum.

Authors:  G Jobin; A Cortot; J Godbillon; M Duval; J P Schoeller; J Hirtz; J J Bernier
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum.

Authors:  N Vidon; D Evard; J Godbillon; M Rongier; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.

Authors:  K J Hoffmann; C G Regårdh; M Aurell; M Ervik; L Jordö
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

10.  The effect of age on the pharmacokinetics of metoprolol and its metabolites.

Authors:  C P Quarterman; M J Kendall; D B Jack
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

View more
  23 in total

1.  Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Authors:  Viera Lukacova; Walter S Woltosz; Michael B Bolger
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

Review 2.  The use of gastrointestinal intubation studies for controlled release development.

Authors:  Steven C Sutton
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

3.  Influence of splitting on dissolution properties of metoprolol tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

4.  G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995--backstory of BCS.

Authors:  Vinod P Shah; Gordon L Amidon
Journal:  AAPS J       Date:  2014-06-25       Impact factor: 4.009

5.  Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.

Authors:  Kiran P Sawant; Ritesh Fule; Mohammed Maniruzzaman; Purnima D Amin
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 6.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.

Authors:  J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

7.  Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.

Authors:  Jan Peter Yska; Jacquelien T M Wanders; Blessing Odigie; Jan A Apers; Marloes Emous; Erik R E Totté; E Christiaan Boerma; Froukje L Ubels; Herman J Woerdenbag; Henderik W Frijlink; Bob Wilffert; Eric N van Roon
Journal:  Eur J Hosp Pharm       Date:  2019-02-15

8.  Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.

Authors:  Ina Gesquiere; Adam S Darwich; Bart Van der Schueren; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Amin Rostami; Veerle Foulon; Patrick Augustijns
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

9.  Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.

Authors:  A Sandberg; I Blomqvist; U E Jonsson; P Lundborg
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.

Authors:  A Sandberg; G Ragnarsson; U E Jonsson; J Sjögren
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.